The pattern of mutated genes appears to be different from those of NEC, which are characterized by co-occurring alteration in TP53 and RB1, and in the driver oncogenes KRAS and BRAF [39,40], the latter especially in colorectal NEC [41]. This evidence concerns the gene BRAF and neuroendocrine carcinoma.